Praxis Precision Medicines (PRAX) Other Non-Current Assets (2019 - 2024)
Praxis Precision Medicines (PRAX) recorded quarterly Other Non-Current Assets of $416000.0 in Q4 2024, little changed quarter-over-quarter from $416000.0 in Q3 2024, and little changed on a YoY basis from $416000.0 in Q1 2024.
Praxis Precision Medicines (PRAX) Other Non-Current Assets (2019 - 2024) Analysis & Trends
Praxis Precision Medicines' Other Non-Current Assets history runs 6 years deep, the most recent figure standing at $416000.0 for Q4 2024.
- In Q4 2024, Other Non-Current Assets changed 0.0% year-over-year to $416000.0; the TTM figure through Dec 2024 stood at $416000.0 (changed 0.0% YoY), while the FY2024 annual figure was $416000.0, changed 0.0% from the prior year.
- Other Non-Current Assets was $416000.0 for Q4 2024 at Praxis Precision Medicines, roughly flat from $416000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $2.1 million in Q3 2020 to a low of $9000.0 in Q1 2021.
- Historically, Other Non-Current Assets has averaged $470333.3 across 5 years, with a median of $416000.0 in 2021.
- The sharpest annual moves came in 2020 and 2022: Other Non-Current Assets plunged 97.58% in 2020, then surged 4522.22% in 2022.
- A 5-year view of Other Non-Current Assets shows it stood at $15000.0 in 2020, then surged by 3046.67% to $472000.0 in 2021, then slipped by 11.86% to $416000.0 in 2022, then changed by 0.0% to $416000.0 in 2023, then changed by 0.0% to $416000.0 in 2024.
- The last three Other Non-Current Assets figures came in at $416000.0 (Q4 2024), $416000.0 (Q3 2024), and $416000.0 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Praxis Precision Medicines | 200.22 Mn | -586.65 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 416,000.00 |
| Sep 30, 2024 | 416,000.00 |
| Jun 30, 2024 | 416,000.00 |
| Mar 31, 2024 | 416,000.00 |
| Dec 31, 2023 | 416,000.00 |
| Sep 30, 2023 | 416,000.00 |
| Jun 30, 2023 | 416,000.00 |
| Mar 31, 2023 | 416,000.00 |
| Dec 31, 2022 | 416,000.00 |
| Sep 30, 2022 | 416,000.00 |
| Jun 30, 2022 | 416,000.00 |
| Mar 31, 2022 | 416,000.00 |
| Dec 31, 2021 | 472,000.00 |
| Sep 30, 2021 | 416,000.00 |
| Jun 30, 2021 | 496,000.00 |
| Mar 31, 2021 | 9,000.00 |
| Dec 31, 2020 | 15,000.00 |
| Sep 30, 2020 | 2.07 Mn |
| Dec 31, 2019 | 620,000.00 |
| Sep 30, 2019 | 600,000.00 |